Evolving research is finding that PCOS may be associated with autoimmune disease—both potentially as an effect (PCOS may be a byproduct of an upregulated immune system and autoimmune disease), as well as a possible cause or even its own version of an autoimmune disease itself.
This discovery may explain why some women may develop PCOS without the textbook markers (such as detectable cysts on the ovaries), but instead experience other inflammatory symptoms, like hormonal imbalances (high testosterone, estrogen dominance, thyroid dysregulation), metabolic dysfunction and intestinal permeability.
The Hormone-Autoimmune Disease Connection
In general, high estrogens excess have been linked to different autoimmune diseases in previous studies.
Every single hormone cell has immune receptors. Hence, the more estrogen, the more immune activity is increased.
The PCOS-Hashimoto’s connection is one of the most common links in research. Hashimoto’s is an autoimmune disease of the thyroid.
One study in 175 patients found that 27% of the women with PCOS also had Hashimoto’s compared to only 8% of controls on bloodwork, and on an ultrasound, over 40% .of PCOS patients had Hashimoto’s.
Likewise other studies have confirmed similar findings—evaluating over 600 women with PCOS and confirming that, Hashimoto’s was the #1 autoimmune disease in the PCOS subjects (perhaps explaining why some women with PCOS gain weight more easily than others and have low Vitamin D levels—their thyroid function!).
All of these findings may make you question whether or not PCOS is a side effect of Hashimoto’s, or is Hashimoto’s a side effect of PCOS?
The latter may be true.
Does PCOS Cause Autoimmune Disease or Vice Versa?
Several studies have shown that PCOS drives inflammation and up-regulates the immune system.
In one study, researchers valuated basic autoimmune disease markers on blood work in 50 PCOS patients and 50 age-matched healthy, fertile women, finding that autoimmune disease markers (like ANA) were significantly higher in PCOS subjects than the control.
Another group of researchers identified a new type of PCOS in infertile older women, characterized by high testosterone and Hashimoto’s. (For reference: Typically PCOS “strikes” in younger menstruating women). They concluded that PCOS must be considered as a precursor (driver) in adrenal insufficiency autoimmunity.
Genetically, women with PCOS symptomology are also more likely to have a FMR1 gene type—associated with autoimmunity and infertility. In fact, one study found almost 50% of women with infertility also have this gene type, and of these, 133 already demonstrated clinical signs of autoimmunity.
Summary: PCOS & Autoimmune Disease
If anything, PCOS clearly has an inflammatory effect on immune balance and higher estrogens pave the way for autoimmune disease tendencies in the body.
Additionally, if these studies alone are not enough to raise a case for the link between PCOS and autoimmune disease, the research on immune-related supports for the treatment of PCOS may be.
Immune boosting liposomal curcumin, resveratrol and Quercetin have been shown to be effective symptom mitigators in PCOS, supporting the immune-PCOS connection theory..
If immune support helps “calm down” the inflammation seen in PCOS, PCOS may very well be more of an immune problem than a hormone imbalance problem alone.
Get Support to Heal from PCOS
Looking for support in the recovery from PCOS or hormone imbalances? Look no further than this 20 minute Health Strategy consult to help you get to the root cause and feel good, inside handout.
- Recalde, G., Moreno-Sosa, T., Yudica, F., Quintero, C. A., Sanchez, M. B., Jahn, G. A., Kalergis, A. M., & Mackern-Oberti, J. P. (2018). Contribution of sex steroids and prolactin to the modulation of T and B cells during autoimmunity. Autoimmunity Reviews, 17(5), 504. https://doi-org.uws.idm.oclc.org/10.1016/j.autrev.2018.03.006. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edsgao&AN=edsgcl.534698415&site=eds-live&scope=site
- Mohammad, I., Starskaia, I., Nagy, T., Guo, J., Yatkin, E., Väänänen, K., Watford, W. T., & Chen, Z. (2018). Estrogen receptor α contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation. Science Signaling, 11(526), 1–N.PAG. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edb&AN=129046342&site=eds-live&scope=site
- Briden, L., Shirin, S., & Prior, J. C. (2020). The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone. Drug Discovery Today: Disease Models, 32(Part B), 71–82. https://doi-org.uws.idm.oclc.org/10.1016/j.ddmod.2020.11.008. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S1740675720300165&site=eds-live&scope=site
- Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004;150:363–9.
- Petrikova, J., Lazurova, I., Dravecka, I., Vrbikova, J., Kozakova, D., Figurova, J., Vaczy, Z., & Rosocha, J. (2015). The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 159(2), 302–306. https://doi-org.uws.idm.oclc.org/10.5507/bp.2014.062. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=25485530&site=eds-live&scope=site
- Kamrul-Hasan, A., Aalpona, F., Mustari, M., Akter, F., Chanda, P., Rahman, M., Mahbub, M., & Selim, S. (2020). Prevalence of thyroid dysfunction and thyroid autoimmunity in polycystic ovary syndrome: A multicenter study from Bangladesh. Thyroid Research & Practice, 17(2), 76–81. https://doi-org.uws.idm.oclc.org/10.4103/trp.trp_6_20. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=144709938&site=eds-live&scope=site
- Krul-Poel, Y. H. M., Koenders, P. P., Steegers-Theunissen, R. P., Ten Boekel, E., Wee, M. M. T., Louwers, Y., Lips, P., Laven, J. S. E., & Simsek, S. (2018). Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study. PloS One, 13(12), e0204748. https://doi-org.uws.idm.oclc.org/10.1371/journal.pone.0204748. retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=30513089&site=eds-live&scope=site
- Štefanić, M., & Tokić, S. (2020). Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies. European Journal of Nutrition, 59(3), 859–872. https://doi-org.uws.idm.oclc.org/10.1007/s00394-019-01991-w. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=31089869&site=eds-live&scope=site
- Makled, A. K., Fathi, H. M., Gomaa, M. F., & Bakr, R. M. (2015). Serologic markers of autoimmunity in women with polycystic ovary syndrome. Middle East Fertility Society Journal, 20(2), 86–90. https://doi-org.uws.idm.oclc.org/10.1016/j.mefs.2014.05.006. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S1110569014000442&site=eds-live&scope=site
- Gleicher, N., Kushnir, V. A., Darmon, S. K., Wang, Q., Zhang, L., Albertini, D. F., & Barad, D. H. (2017). New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. Journal of Steroid Biochemistry and Molecular Biology, 167, 144–152. https://doi-org.uws.idm.oclc.org/10.1016/j.jsbmb.2016.12.004. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0960076016303430&site=eds-live&scope=site
- Gleicher, N., Weghofer, A., Lee, I. H., & Barad, D. H. (2010). FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy Chance. PLoS ONE, 5(12), 1–6. https://doi-org.uws.idm.oclc.org/10.1371/journal.pone.0015303. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=59390079&site=eds-live&scope=site
- Heshmati, J., Golab, F., Morvaridzadeh, M., Potter, E., Akbari-Fakhrabadi, M., Farsi, F., Tanbakooei, S., & Shidfar, F. (2020). The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial. Diabetes & Metabolic Syndrome, 14(2), 77–82. https://doi-org.uws.idm.oclc.org/10.1016/j.dsx.2020.01.002/. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=31991296&site=eds-live&scope=site
- Mansour, A., Samadi, M., Sanginabadi, M., Gerami, H., Karimi, S., Hosseini, S., Shirzad, N., Hekmatdoost, A., Mahdavi-Gorabi, A., Mohajeri-Tehrani, M. R., & Qorbani, M. (2021). Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS. Clinical Nutrition, 40(6), 4106–4112. https://doi-org.uws.idm.oclc.org/10.1016/j.clnu.2021.02.004. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=151058618&site=eds-live&scope=site
- Khorshidi, M., Moini, A., Alipoor, E., Rezvan, N., Gorgani-Firuzjaee, S., Yaseri, M., & Hosseinzadeh-Attar, M. J. (2018). The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome. Phytotherapy Research : PTR, 32(11), 2282–2289. https://doi-org.uws.idm.oclc.org/10.1002/ptr.6166. Retrieved from: https://uws.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=30062709&site=eds-live&scope=site